{name}
{subtitle}
Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)
city
~72 mi. (Kursk, Russia, +159 more cities)
facility
Kursk Regional Clinical Oncology Dispensary ( Site 0854)
drug
cisplatin, +2 more drugs
drug type
chemotherapy, +1 more type